11.12.2007 13:30:00
|
Immersion Medical Offers Cardiac Surgical Simulator Module for Coronary Valve Replacement
Immersion Corporation (Nasdaq:IMMR), a leading developer and licensor of touch
feedback technology (http://www.immersion.com/corporate/),
today announced that Immersion Medical has launched a new module for its
CathLabVR™ Surgical
Simulator (http://www.immersion.com/medical/products/endovascular/).
The new Transcatheter Aortic Valve module helps train physicians for
minimally invasive coronary valve replacement.
An estimated 450,000 patients in the U.S. suffer from severe stenosis
(narrowing) of coronary valves, which impedes blood flow and can lead to
heart failure. More than half of the patients affected in the U.S. are
over 75, an age group expected to increase in the coming years. The
medical needs of many patients with severe aortic stenosis have been
unmet.(1) Patients may exhibit few symptoms until an abrupt change
occurs, and surgeons and patients are less likely to opt for invasive
surgery to treat stenosis that is not pronounced, a situation that can
lead to life threatening symptoms or death. Even when stenosis is known
to be severe, open heart surgery may not be possible if the patient’s
health is compromised in other ways. Minimally invasive valve
replacements can provide a safer alternative to open-heart surgery with
shorter procedure and recovery times. It is likely that with a less
invasive treatment more patients could and would be treated. Therefore,
valve replacement interventions are seen by many as the future standard
of care for many high risk patients. With its realistic surgical
simulations, Immersion Medical’s new cardiac
surgical simulation module can help accelerate learning and adoption of
these minimally invasive life-saving procedures.
"The CathLabVR Surgical Simulator’s
cardiac surgery module was created to keep pace with advancements in
technologies and techniques,” said Kevin
Kunkler, M.D., vice president, and medical director of Immersion
Medical. "The module helps doctors-in-training
to learn the core concepts of these procedures and surgeons and
interventionalists to master the necessary steps and gain experience and
knowledge transferable to real-life cases.”
With eight cases that provide experience with four anatomies, the
Transcatheter Aortic Valve surgical simulation module provides practice
in:
Navigation through either the femoral artery or through the apex of
the left ventricle
Balloon inflation to pre-dilate the aortic valve
Use of fluoroscopy, cineangiography, and contrast injection to
visualize and measure the aortic valve and determine a site for its
correct placement
The CathLabVR Surgical Simulator uses actual diagnostic and therapeutic
devices, such as catheters, balloons, stents, and distal protection
devices. A procedural-based system, it allows trainees to practice and
repeat cases of varying levels of difficulty and to experience and
manage complications. The system’s
appropriately responsive physiology is reflected in vital-sign changes,
hemodynamic wave tracings, and patient audio responses that enhance the
decision-making process. An added benefit is the realistic haptic
feedback that mimics the feel of the procedure. Visual aides, including
the virtual 3D anatomy model and live fluoroscopy, help trainees
understand vascular anatomy and device operation. A comprehensive
performance report, automatically generated after completion of the
surgical simulation, allows objective assessment of the user.
The CathLabVR Surgical Simulator provides a realistic training
environment to help practicing physicians safely train in new procedures
to keep pace with medical innovations. The system can also help prepare
fellows to meet the requirements of the Accreditation Council for
Graduate Medical Education (ACGME), which call for a minimum of 300
cardiac catheterizations before training in coronary interventions,
followed by a minimum of 12 months and at least 250 interventions.
(1) Leon, Martin B. 2006. Transcatheter Aortic Valve Replacement:
Rationale, Early Clinical Results. Columbia University Medical Center
Cardiovascular Research Foundation.
About Immersion Medical, Inc. (www.immersionmedical.com)
Immersion Medical, Inc. designs, manufactures, and markets
computer-based surgical
simulation training systems (http://www.immersion.com/medical/surgical_sim.php)
worldwide. The medical and surgical simulators integrate proprietary
computer software and tactile feedback robotics to create highly
realistic medical simulations that help train clinicians. The company’s
key product lines are the Virtual IV intravenous simulator, Endoscopy
AccuTouch®
Simulator, CathLabVR™
surgical simulator, and LaparoscopyVR™
surgical simulation system.
About Immersion (www.immersion.com)
Founded in 1993, Immersion Corporation is a recognized leader in
developing, licensing, and marketing digital touch technology and
products. Using Immersion’s advanced touch
feedback technology (http://www.immersion.com/corporate/products/),
electronic user interfaces can be made more productive, compelling,
entertaining, or safer. Immersion’s
technology is deployed across automotive, entertainment, industrial
controls, medical training, mobility, and three-dimensional simulation
markets. Immersion’s patent portfolio
includes over 700 issued or pending patents in the U.S. and other
countries.
Forward Looking Statements
This press release contains "forward-looking
statements” that involve risks and
uncertainties, as well as assumptions that, if they never materialize or
prove incorrect, could cause the results of Immersion Corporation and
its consolidated subsidiaries to differ materially from those expressed
or implied by such forward-looking statements.
All statements, other than the statements of historical fact, are
statements that may be deemed forward-looking statements, including any
projections of earnings, revenues, or other financial matters; any
statements of the plans, strategies, and objectives of management for
future operations; any statements concerning the benefits of medical
simulators or continued customer acceptance of medical simulators;
or consumer and market acceptance of force feedback products in general;
proposed products or services; any statements regarding future economic
conditions or performance; statements of belief; and any statement or
assumptions underlying any of the foregoing. Immersion’s
actual results might differ materially from those stated or implied by
such forward-looking statements due to risks and uncertainties
associated with our business which include, but are not limited to,
delay in or failure to achieve commercial demand for our products or a
delay in or failure to achieve the acceptance of force feedback as a
critical user experience.
For a more detailed discussion of these factors, and other factors that
could cause actual results to vary materially, interested parties should
review the risk factors listed in our most current Form 10-Q, which is
on file with the U.S. Securities and Exchange Commission. The
forward-looking statements in this press release reflect our beliefs and
predictions as of the date of this release. We disclaim any obligation
to update these forward-looking statements as a result of financial,
business, or any other developments occurring after the date of this
release.
Immersion, the Immersion logo, AccuTouch, CathLabVR, and LaparoscopyVR
are trademarks of Immersion Corporation in the United States and other
countries. All other trademarks are the property of their respective
owners.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Immersion Corp.mehr Nachrichten
Keine Nachrichten verfügbar. |